… of scleroderma (≤2 years), whereas all patients with a progressive course under ECP had
had scleroderma … effective treatment modality in severe scleroderma particularly when started …

… photopheresis, performed as described above, is an effective treatment in systemic
sclerosis… small to justify photopheresis as a regular treatment. (J Am Acad Dermatol 1999;41:915-22.) …

… therapies used for patients with scleroderma, the disease-… of extracorporeal photopheresis
(ECP) in scleroderma treatment. … of extracorporeal photochemotherapy in systemic sclerosis. …

… Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after
receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of …

… base for extracorporeal photopheresis on skin scores in patients with systemic sclerosis
was … a superior effect when compared to no treatment, sham photopheresis, or D-penicillamine. …

… PSS were treated with photopheresis on 2 successive days … of patients had to photopheresis
treatment at an average of … extended use of extracorporeal photochemotherapy in the …

… Systemic sclerosis is an autoimmune disorder characterized … In its severe, progressive form,
systemic sclerosis is … beneficial clinical effects in patients with systemic sclerosis,15, 16 and …

… Kaplan-Meier curve showing 20-year systemic sclerosis (SSc)-related survival (n = 59) in
patients who had received extracorporeal photopheresis. 51 patients (86.4%) survived within a …

… Extracorporeal photochemotherapy in systemic sclerosis and severe morphea. … Treatment
of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis). J …

… or just photopheresis) is a … severe and difficult-to-treat conditions, most widely in graft-versus-host
disease (GVHD) after allogeneic stem cell transplantation, but also in systemic sclerosis…